Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Agenus Inc (NASDAQ:AGEN)

6.87
Delayed Data
As of 3:59pm ET
 -0.24 / -3.38%
Today’s Change
2.61
Today|||52-Week Range
7.31
+51.32%
Year-to-Date

Today’s Trading

Previous close7.11
Today’s open7.11
Day’s range6.85 - 7.18
Volume1,039,421
Average volume (3 months)1,085,969
Market cap$618.6M
Dividend yield--
Data as of 3:59pm ET, 09/29/2016

Growth & Valuation

Earnings growth (last year)-59.15%
Earnings growth (this year)-12.21%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+255.67%
P/E ratioNM
Price/Sales14.31
Price/Book8.68

Competitors

 Today’s
change
Today’s
% change
NTLAIntellia Therapeutic...-0.02-0.12%
ATRAAtara Biotherapeutic...-1.15-5.27%
NVAXNovavax Inc-0.14-6.36%
NKNantKwest Inc-0.42-5.37%
Data as of 4:14pm ET, 09/29/2016

Financials

Next reporting dateOctober 20, 2016
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$24.8M
Annual profit (last year)-$87.9M
Net profit margin-354.12%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Garo H. Armen
Chief Financial &
Accounting Officer
Christine M. Klaskin
Corporate headquarters
Lexington, Massachusetts

Forecasts

Search for Jobs